AU2002313236A1 - Medicinal compositions - Google Patents

Medicinal compositions

Info

Publication number: AU2002313236A1
Authority: AU; Australia
Prior art keywords: medicinal compositions; medicinal; compositions
Prior art date: 2001-06-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002313236A

Other versions

AU2002313236B2 (en

AU2002313236B8 (en

Inventor

Kazutaka Higaki

Toshikiro Kimura

Takanori Minami

Masateru Miyake

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Otsuka Pharmaceutical Co Ltd

Original Assignee

Otsuka Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-14

Filing date

2002-06-14

Publication date

2003-05-15

2002-06-14 Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd

2002-06-14 Priority claimed from PCT/JP2002/005954 external-priority patent/WO2002102414A1/en

2003-01-02 Application granted granted Critical

2003-01-02 Publication of AU2002313236B8 publication Critical patent/AU2002313236B8/en

2003-05-15 Publication of AU2002313236A1 publication Critical patent/AU2002313236A1/en

2007-07-26 Publication of AU2002313236B2 publication Critical patent/AU2002313236B2/en

2022-06-14 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
JP2001180373		2001-06-14
JP2001-180373		2001-06-14
JP2001-298839		2001-09-28
JP2001298839		2001-09-28
PCT/JP2002/005954 WO2002102414A1 (en)	2001-06-14	2002-06-14	Medicinal compositions

Publications (3)

Publication Number	Publication Date
AU2002313236B8 AU2002313236B8 (en)	2003-01-02
AU2002313236A1 true AU2002313236A1 (en)	2003-05-15
AU2002313236B2 AU2002313236B2 (en)	2007-07-26

Family

ID=26616910

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002313236A Ceased AU2002313236B2 (en)	2001-06-14	2002-06-14	Medicinal compositions

Country Status (9)

Country	Link
US (3)	US6884768B2 (en)
EP (2)	EP1407785A4 (en)
KR (3)	KR100994221B1 (en)
CN (2)	CN1813699B (en)
AU (1)	AU2002313236B2 (en)
CA (2)	CA2449952C (en)
MX (1)	MXPA03011538A (en)
TW (1)	TWI239247B (en)
WO (1)	WO2002102414A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE44578E1 (en)	2000-04-10	2013-11-05	Teva Pharmaceutical Industries, Ltd.	Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
US20050032811A1 (en) *	2003-08-06	2005-02-10	Josiah Brown	Methods for administering aripiprazole
WO2005023225A1 (en) *	2003-09-05	2005-03-17	Ranbaxy Laboratories Limited	Cilostazol adsorbate
AU2004285448C1 (en)	2003-10-23	2021-08-19	Otsuka Pharmaceutical Co., Ltd.	Controlled release sterile injectable aripiprazole formulation and method
LT2422789T (en) *	2004-05-19	2018-03-12	Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center	Injectable coposition comprising sodium deoxycholate
US20060127468A1 (en) *	2004-05-19	2006-06-15	Kolodney Michael S	Methods and related compositions for reduction of fat and skin tightening
US7754230B2 (en) *	2004-05-19	2010-07-13	The Regents Of The University Of California	Methods and related compositions for reduction of fat
US9114069B2 (en) *	2004-08-25	2015-08-25	Aegis Therapeutics, Llc	Antibacterial compositions for drug administration
US20060046962A1 (en)	2004-08-25	2006-03-02	Aegis Therapeutics Llc	Absorption enhancers for drug administration
US20090047347A1 (en) *	2005-07-29	2009-02-19	Aegis Therapeutics, Inc.	Compositions for Drug Administration
US20140162965A1 (en)	2004-08-25	2014-06-12	Aegis Therapeutics, Inc.	Compositions for oral drug administration
US9895444B2 (en)	2004-08-25	2018-02-20	Aegis Therapeutics, Llc	Compositions for drug administration
US20110257096A1 (en) *	2004-08-25	2011-10-20	Aegis Therapeutics, Inc.	Compositions for drug administration
US20080206348A1 (en) *	2004-09-17	2008-08-28	Deepak Murpani	Cilostazol-Containing Pharmaceutical Composition Based On Particles Of Less Than 50 Micrometers
TWI363626B (en) *	2004-11-15	2012-05-11	Otsuka Pharma Co Ltd	Aqueous ophthalmic suspension of crystalline rebamipide
JP2009508859A (en) *	2005-09-15	2009-03-05	エランファーマインターナショナルリミテッド	Nanoparticulate aripiprazole formulation
US8920918B2 (en) *	2005-10-31	2014-12-30	Kee Action Sports Technology Holdings, Llc	Oil and polyethylene glycol fill material for use in paintball shells
TW200808375A (en) *	2006-05-12	2008-02-16	Otsuka Pharma Co Ltd	Hydrogel suspension and manufacturing process thereof
US8226949B2 (en)	2006-06-23	2012-07-24	Aegis Therapeutics Llc	Stabilizing alkylglycoside compositions and methods thereof
US20110165236A1 (en) *	2006-09-22	2011-07-07	Biokey, Inc.	Controlled release hydrogel formulation
US20080075785A1 (en) *	2006-09-22	2008-03-27	San-Laung Chow	Controlled release hydrogel formulation
TWI415629B (en) *	2006-10-26	2013-11-21	Otsuka Pharma Co Ltd	Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof
EP2011491A1 (en) *	2007-07-05	2009-01-07	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Anticonvulsive pharmaceutical compositions
JP2010532331A (en)	2007-07-05	2010-10-07	アンセルム（アンスチチュナショナルドゥラサンテエドゥラルシェルシュメディカル）	Anticonvulsant pharmaceutical composition
US9457026B2 (en)	2007-07-31	2016-10-04	Otsuka Pharmaceutical Co., Ltd.	Methods for producing aripiprazole suspension and freeze-dried formulation
KR20150064227A (en) *	2007-10-19	2015-06-10	오츠카 세이야쿠 가부시키가이샤	Matrix-type pharmaceutical solid preparation
AU2009228093B2 (en)	2008-03-28	2014-08-07	Neurelis, Inc.	Administration of benzodiazepine compositions
PL2165702T3 (en)	2008-09-17	2012-04-30	Helm Ag	Stable and readily dissolved compositions of candesartan cilexetil prepared with wet granulation
US8440631B2 (en)	2008-12-22	2013-05-14	Aegis Therapeutics, Llc	Compositions for drug administration
US8101593B2 (en)	2009-03-03	2012-01-24	Kythera Biopharmaceuticals, Inc.	Formulations of deoxycholic acid and salts thereof
US20120245080A1 (en) *	2009-04-15	2012-09-27	Bmg Pharma Llc	Mineral salt-sulfonic acid compositions and methods of use
CN102145003B (en) *	2010-02-08	2015-04-22	张立英	Medicinal composition containing insoluble medicament
EP2902019B1 (en) *	2010-08-04	2017-10-04	Pierrel Pharma S.R.L.	Compositions comprising inclusion complexes of cyclodextrins with spermidine for use in oral care
PL2898881T3 (en) *	2010-08-04	2019-04-30	Pierrel Pharma S R L	Compositions comprising supramolecular complexes of polyanionic polymers and spermidine for use in the treatment of periodontum and damaged oral tissue
KR101277021B1 (en) *	2010-12-28	2013-06-24	주식회사 드림파마	Oral controlled release double-layered rebamipide-contained formulation using gastro-retentive drug delivery system and process for the preparation thereof
CA2827643C (en)	2011-02-18	2019-05-07	Kythera Biopharmaceuticals, Inc.	Treatment of submental fat
US8653058B2 (en)	2011-04-05	2014-02-18	Kythera Biopharmaceuticals, Inc.	Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
PT3415139T (en)	2011-06-14	2022-06-20	Neurelis Inc	Administration of benzodiazepine
CN102357084B (en) *	2011-10-11	2014-02-26	广东彼迪药业有限公司	Enalapril maleate tablet composition and its preparation and use
US10918612B2 (en) *	2013-01-22	2021-02-16	Markus Zwickl	Combinations with 2-aminoethanesulfonic acid
US20160136282A1 (en) *	2014-11-18	2016-05-19	Genovate Biotechnology Co., Ltd.	Novel formulation of cilostazol, a quinolinone-derivative used for alleviating the symptom of intermittent claudication in patients with peripheral vascular disease
PE20180690A1 (en)	2015-04-27	2018-04-23	Intercept Pharmaceuticals Inc	OBETICOLIC ACID COMPOSITIONS AND METHODS OF USE

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4591605A (en)	1981-11-10	1986-05-27	Research Foundation Of State University Of New York	Method and ingestible formulation for inhibiting the secretion of stomach acid
NZ212053A (en) *	1984-05-17	1988-02-29	Merrell Dow Pharma	Polyamine containing pharmaceutical compositions for treating neoplasms
JP2911496B2 (en) *	1989-09-11	1999-06-23	帝國製薬株式会社	Highly absorbable vaginal agent containing bioactive polypeptide
JPH03275633A (en) *	1990-03-23	1991-12-06	Teikoku Seiyaku Co Ltd	Absorbefacient for physiologically active polypeptide
US5328844A (en) *	1990-05-09	1994-07-12	University Of Colorado Foundation, Inc.	Culture media for mammalian cells
JPH0733667A (en) *	1992-07-03	1995-02-03	Japan Tobacco Inc	Aqueous solution of 4,6-o-hydroxyphosphorylglucosamine derivative and method of making the same derivative water-soluble
JPH0656643A (en) *	1992-08-03	1994-03-01	Shiseido Co Ltd	Skin preparation for external use
JPH06192108A (en) *	1992-12-25	1994-07-12	Kanebo Ltd	Calcium gluconate oral solution
JP3690820B2 (en)	1993-02-25	2005-08-31	雪印乳業株式会社	Nutritional composition for infants
SE9404196D0 (en)	1994-12-02	1994-12-02	Astra Ab	New antithrombotic formulation
JP3297969B2 (en) *	1994-12-26	2002-07-02	ライオン株式会社	Eye drops
AU4357096A (en) *	1995-01-10	1996-07-31	Otsuka Pharmaceutical Co., Ltd.	Resin particle, medical material and pharmaceutical preparation containing said resin particle
MX9705954A (en) *	1995-02-03	1998-02-28	Cosmederm Technologies	Formulations and methods for reducing skin irritation.
JPH1025255A (en)	1996-07-11	1998-01-27	Taisho Pharmaceut Co Ltd	Poorly soluble drug with improved solubility
JP3677376B2 (en)	1996-08-13	2005-07-27	武田薬品工業株式会社	Medicine
JPH10262607A (en)	1997-03-28	1998-10-06	Snow Brand Milk Prod Co Ltd	Nutrient composition for infant
JPH1160486A (en) *	1997-06-09	1999-03-02	Taisho Pharmaceut Co Ltd	Thiamine compound liquid
JPH1160487A (en) *	1997-06-09	1999-03-02	Taisho Pharmaceut Co Ltd	Vitamin B1 derivative combination liquid
JP4403590B2 (en)	1997-10-02	2010-01-27	大正製薬株式会社	Vitamin B1 combination liquid
BR9815347A (en) *	1997-12-03	2000-10-10	Taisho Pharmaceutical Co Ltd	Liquid composition, and, agent and process to prevent the liquid composition containing minoxidil from changing color.
PT1113785E (en) *	1998-07-24	2005-08-31	Seo Hong Yoo	CLEANED AQUEOUS SOLVENTS OF BILIARY ACIDS
US6207190B1 (en) *	1998-08-13	2001-03-27	Chronorx, Llc	Dosage forms for the treatment of the chronic glaucomas

2002
- 2002-06-14 MX MXPA03011538A patent/MXPA03011538A/en active IP Right Grant
- 2002-06-14 CN CN2005101272199A patent/CN1813699B/en not_active Expired - Fee Related
- 2002-06-14 CA CA2449952A patent/CA2449952C/en not_active Expired - Fee Related
- 2002-06-14 EP EP02738715A patent/EP1407785A4/en not_active Withdrawn
- 2002-06-14 CN CNB028118693A patent/CN100350977C/en not_active Expired - Fee Related
- 2002-06-14 KR KR1020087001568A patent/KR100994221B1/en not_active Expired - Fee Related
- 2002-06-14 US US10/480,598 patent/US6884768B2/en not_active Expired - Fee Related
- 2002-06-14 CA CA2662967A patent/CA2662967C/en not_active Expired - Fee Related
- 2002-06-14 KR KR1020097000807A patent/KR20090019915A/en not_active Ceased
- 2002-06-14 WO PCT/JP2002/005954 patent/WO2002102414A1/en not_active Ceased
- 2002-06-14 TW TW091113019A patent/TWI239247B/en not_active IP Right Cessation
- 2002-06-14 EP EP13153254.1A patent/EP2591806A1/en not_active Withdrawn
- 2002-06-14 KR KR1020037016321A patent/KR100943309B1/en not_active Expired - Fee Related
- 2002-06-14 AU AU2002313236A patent/AU2002313236B2/en not_active Ceased
2004
- 2004-12-15 US US11/011,035 patent/US7008920B2/en not_active Expired - Fee Related
- 2004-12-15 US US11/011,278 patent/US7531499B2/en not_active Expired - Fee Related

Publication	Publication Date	Title
AU2002313236A1 (en)	2003-05-15	Medicinal compositions
AU781269C (en)	2006-11-30	Pharmaceutical compositions
EP1407785A4 (en)	2009-12-02	Medicinal compositions
AU2001250420A1 (en)	2001-10-23	Pharmaceutical compositions
AU2001274307A1 (en)	2002-01-02	Pharmaceutical compositions
AU2002302147A1 (en)	2003-06-12	Pharmaceutical composition
AU2002258221A1 (en)	2003-05-08	Medicinal composition
AU2002214324A1 (en)	2002-08-08	Medicinal compositions
AU2001273919A1 (en)	2001-10-23	Pharmaceutical compositions
AU2002365093A1 (en)	2003-07-09	Therapeutic compositions
AUPR600601A0 (en)	2001-07-26	Therapeutic compositions
AU2002321808A1 (en)	2003-02-24	Dental compositions
AU2002354460A1 (en)	2003-07-09	Medicinal composition
AU2001282541A1 (en)	2002-06-13	Medicinal compositions
AUPR529701A0 (en)	2001-06-21	Pharmaceutical composition
AU2002346223A1 (en)	2003-05-15	Medicinal compositions
AU2001285737A1 (en)	2001-12-24	Pharmaceutical compositions
AU2002327341A1 (en)	2003-02-24	Thrombomodulin-containing medicinal compositions
AU2002306341A1 (en)	2002-12-23	Medicinal compositions
AU2002256916A1 (en)	2002-12-09	Medicinal compositions
AU2002226759A1 (en)	2002-08-12	Medicinal composition
AU2002326822A1 (en)	2003-04-22	Pro-micelle pharmaceutical compositions
AU2002100921A4 (en)	2003-06-05	Pharmaceutical composition
AU2002334736A1 (en)	2003-04-07	Fondant-based pharmaceutical composition
HK1062631A (en)	2004-11-19	Pharmaceutical composition